Kovitz Investment Group Partners, LLC Novo Cure LTD Transaction History
Kovitz Investment Group Partners, LLC
- $23.6 Billion
- Q3 2025
A detailed history of Kovitz Investment Group Partners, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 19,574 shares of NVCR stock, worth $213,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,574Holding current value
$213,748% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
280Shares Held
76.8MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$114 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$75.4 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$69.7 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$29.2 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.15B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...